Skip to content

Clinical trials

Phase 2 Mesothelioma trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Mesothelioma Phase: Phase 2 Country / region: Italy Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20081
20132
20151
20161
20171
20191
20201

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Unknown status2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer2
Armando Santoro, MD1
Azienda USL Reggio Emilia - IRCCS1
Gruppo Italiano MEsotelioma1
Gruppo Oncologico Italiano di Ricerca Clinica1
Mario Negri Institute for Pharmacological Research1
Swiss Cancer Institute1
University of Turin, Italy1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Mesothelioma9
Lung Neoplasms2
Mesothelioma, Malignant2
Neoplasms1
Pancreatic Neoplasms1
Stomach Neoplasms1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.